论文部分内容阅读
我科1996年8月～1997年6月以云南灯盏花注射液治疗脑梗塞患者84例,并与1996年8月以前治疗的78例脑梗塞患者进行对照,取得满意疗效,报告如下。 对象和方法 1.对象 治疗组和对照组均符合1986年第二次全国脑血管病学术会议诊断标准,经头颅CT确诊为脑梗塞。治疗组84例,男45例,女39例,年龄43～79岁,平均63.77岁;急性期(<1个月)28例,恢复期(l～6个月)35例,后遗症期(>6个月)21例;病程12小时～7年。对照组78例,男38例,女40例,年龄44～76岁,平均63.42岁;急性期19例,恢复期28例,后遗症期31例;病程10小时～6年。
Our department from August 1996 to June 1997 in Yunnan Erigeron injection treatment of 84 patients with cerebral infarction, and in August 1996 before treatment 78 cases of cerebral infarction patients were controlled and achieved satisfactory results, the report is as follows. Subjects and methods 1. Subject treatment group and control group are in line with the 1986 National Conference on cerebrovascular disease diagnostic criteria, the diagnosis of cerebral infarction by CT. The treatment group of 84 patients, 45 males and 39 females, aged 43 to 79 years old, an average of 63.77 years; 28 cases of acute (<1 month), recovery period (l ~ 6 months) 35 cases of sequelae> 6 months) in 21 cases; duration of 12 hours to 7 years. The control group of 78 patients, 38 males and 40 females, aged 44 to 76 years, an average of 63.42 years; 19 cases of acute, recovery of 28 cases, 31 cases of sequelae; duration of 10 hours to 6 years.